Acute Myeloid Leukemia (AML) Rounds
 

PROGRAM AGENDA

6:15 PM      Dinner and Networking 

7:00 PM      AML Introduction and Welcome
                   Jeffrey Lancet, MD & Lauren Berger, MPH
 
7:15 PM      Effective use of molecular diagnostic data in AML therapeutic decision- 
                   making
                         Maxim Norkin, MD, PhD
 
7:45 PM      Management of the elderly patient with AML
                              Kendra Sweet, MD, MS & 
Chetasi Talati, MD
 
8:15 PM       Evolving role of FLT3 inhibitors and other targeted agents in AML
                         Julio Hajdenberg, MD, FACP & 
Talia Zahra, MD
 
8:45 PM     Informal case presentations from the audience with discussions by panelists
                  and others - Jeffrey Lancet, MD 

9:00 PM     Adjourn